Literature DB >> 16627850

Best evidence topic report. Beta-Blockers in cocaine induced acute coronary syndrome.

Ayan Sen1, Tim Fairbairn, Freya Levy.   

Abstract

A short cut review was carried out to establish whether beta blockers should be used in the treatment of chest pain associated with cocaine use. 12 papers were found, of which two presented the best evidence to answer the clinical question. The author, date and country of publication, patient group studied, study type, relevant outcomes, results and study weaknesses of these best papers are tabulated. The clinical bottom line is that Beta Blockers should not be used in the treatment of cocaine induced myocardial ischaemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16627850      PMCID: PMC2564096          DOI: 10.1136/emj.2006.036582

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  2 in total

1.  Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade.

Authors:  R A Lange; R G Cigarroa; E D Flores; W McBride; A S Kim; P J Wells; J B Bedotto; R S Danziger; L D Hillis
Journal:  Ann Intern Med       Date:  1990-06-15       Impact factor: 25.391

2.  Influence of labetalol on cocaine-induced coronary vasoconstriction in humans.

Authors:  J D Boehrer; D J Moliterno; J E Willard; L D Hillis; R A Lange
Journal:  Am J Med       Date:  1993-06       Impact factor: 4.965

  2 in total
  2 in total

Review 1.  Cocaine and Cardiotoxicity: A Literature Review.

Authors:  Joseph V Pergolizzi; Peter Magnusson; Jo Ann K LeQuang; Frank Breve; Giustino Varrassi
Journal:  Cureus       Date:  2021-04-20

2.  Discrepancies between the medical record and the reports of patients with acute coronary syndrome regarding important aspects of the medical history.

Authors:  Chete Eze-Nliam; Kellie Cain; Kasey Bond; Keith Forlenza; Rachel Jankowski; Gina Magyar-Russell; Gayane Yenokyan; Roy C Ziegelstein
Journal:  BMC Health Serv Res       Date:  2012-03-26       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.